Overview

Study to Compare Two Formulations of Lamotrigine in Healthy Subjects

Status:
Completed
Trial end date:
2007-01-25
Target enrollment:
Participant gender:
Summary
This study intends to compare the pharmacokinetic characteristics, safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Anticonvulsants
Lamotrigine